» Articles » PMID: 25813828

Interaction of Astrocytes and T Cells in Physiological and Pathological Conditions

Overview
Journal Brain Res
Specialty Neurology
Date 2015 Mar 28
PMID 25813828
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

The central nervous system (CNS) has long been recognized as a site of 'immune privilege' because of the existence of the blood brain barrier (BBB) which presumably isolates CNS from the peripheral immunosurveillance. Different from the peripheral organs, CNS is unique in response to all forms of CNS injury and disease which is mainly mediated by resident microglia and astrocyte. There is increasing evidence that immune cells are not only involved in neuroinflammation process but also the maintenance of CNS homeostasis. T cells, an important immune cell population, are involved in the pathogenesis of some neurological diseases by inducing either innate or adaptive immune responses. Astrocytes, which are the most abundant cell type in the CNS, maintain the integrity of BBB and actively participate in the initiation and progression of neurological diseases. Surprisingly, how astrocytes and T cells interact and the consequences of their interaction are not clear. In this review we briefly summarized T cells diversity and astrocyte function. Then, we examined the evidence for the astrocytes and T cells interaction under physiological and pathological conditions including ischemic stroke, multiple sclerosis, viral infection, and Alzheimer's disease. This article is part of a Special Issue entitled SI: Cell Interactions In Stroke.

Citing Articles

Glia Modulates Immune Responses in the Retina Through Distinct MHC Pathways.

Intonti S, Kokona D, Zinkernagel M, Enzmann V, Stein J, Conedera F Glia. 2025; 73(4):822-839.

PMID: 39873321 PMC: 11845847. DOI: 10.1002/glia.24656.


Role of astrocytes connexins - pannexins in acute brain injury.

Tichauer J, Rovegno M Neurotherapeutics. 2025; 22(1):e00523.

PMID: 39848901 PMC: 11840357. DOI: 10.1016/j.neurot.2025.e00523.


Targeting brain-peripheral immune responses for secondary brain injury after ischemic and hemorrhagic stroke.

Duan M, Xu Y, Li Y, Feng H, Chen Y J Neuroinflammation. 2024; 21(1):102.

PMID: 38637850 PMC: 11025216. DOI: 10.1186/s12974-024-03101-y.


Metabolic reprogramming and signalling cross-talks in tumour-immune interaction: a system-level exploration.

Shukla M, Bhowmick R, Ganguli P, Sarkar R R Soc Open Sci. 2024; 11(3):231574.

PMID: 38481985 PMC: 10933535. DOI: 10.1098/rsos.231574.


Neuroinflammation and acquired traumatic CNS injury: a mini review.

Theus M Front Neurol. 2024; 15:1334847.

PMID: 38450073 PMC: 10915049. DOI: 10.3389/fneur.2024.1334847.


References
1.
Pacheco R, Oliva H, Martinez-Navio J, Climent N, Ciruela F, Gatell J . Glutamate released by dendritic cells as a novel modulator of T cell activation. J Immunol. 2006; 177(10):6695-704. DOI: 10.4049/jimmunol.177.10.6695. View

2.
Starbeck-Miller G, Xue H, Harty J . IL-12 and type I interferon prolong the division of activated CD8 T cells by maintaining high-affinity IL-2 signaling in vivo. J Exp Med. 2013; 211(1):105-20. PMC: 3892973. DOI: 10.1084/jem.20130901. View

3.
Kang Z, Altuntas C, Gulen M, Liu C, Giltiay N, Qin H . Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis. Immunity. 2010; 32(3):414-25. PMC: 3073618. DOI: 10.1016/j.immuni.2010.03.004. View

4.
McQuillan K, Lynch M, Mills K . Activation of mixed glia by Abeta-specific Th1 and Th17 cells and its regulation by Th2 cells. Brain Behav Immun. 2010; 24(4):598-607. DOI: 10.1016/j.bbi.2010.01.003. View

5.
Fletcher J, Lalor S, Sweeney C, Tubridy N, Mills K . T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol. 2010; 162(1):1-11. PMC: 2990924. DOI: 10.1111/j.1365-2249.2010.04143.x. View